Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

158
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
158
Obesity01:24

Obesity

366
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
366
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

21
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
21

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enantioselective Construction of Inherently Chiral Saddle-Shaped Azepines via Palladium-Catalyzed Intramolecular C-H Arylation.

Organic letters·2026
Same author

Modular Synthesis of Spiroisochromans with Spiro Quaternary Carbon Centers Via TBAT-Promoted Multicomponent Cascade Reactions.

Organic letters·2026
Same author

Aryne Relay-Triggered Three-Component Cascade via <i>In Situ</i> <i>o</i>-QDM Generation: Synthesis of <i>N,O</i>-Spiroheterocycles and Benzo[<i>f</i>]isoindole-1,3(2<i>H</i>)-diones.

Organic letters·2026
Same author

APOE+ macrophages induce tumor cell metastatic characteristics via TNFSF12/TNFRSF12A signaling, correlating with poor patient prognosis.

Cancer cell international·2026
Same author

Discovery of novel anthraquinone-based P2X7R antagonist that reinvigorates anti-tumor immunity and overcomes PD-1 resistance in breast cancer.

European journal of medicinal chemistry·2026
Same author

Progress in the Synthesis of Aspidospermidine.

Chemistry, an Asian journal·2026

Related Experiment Video

Updated: May 27, 2025

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

67.8K

Association between triglyceride‑glucose index as a marker of insulin resistance and the risk of malignant melanoma:

Jiukang Sun1, Zhihang Han2, Chuanjun Song3

  • 1Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China.

Oncology Letters
|February 19, 2025
PubMed
Summary
This summary is machine-generated.

The triglyceride glucose (TyG) index, an indicator of insulin resistance, is a significant risk factor for malignant melanoma incidence. Higher TyG index levels correlate with increased melanoma risk, suggesting its potential as a diagnostic biomarker.

Keywords:
biomarkerinsulin resistancemalignant melanomatriglyceride-glucose index

More Related Videos

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

187
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

9.6K

Related Experiment Videos

Last Updated: May 27, 2025

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT

Published on: January 7, 2018

67.8K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

187
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
08:47

Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy

Published on: December 7, 2017

9.6K

Area of Science:

  • Oncology
  • Endocrinology
  • Dermatology

Background:

  • Malignant melanoma incidence and mortality rates are rising globally.
  • Early detection is crucial for melanoma prognosis, yet risk factors remain under-explored.
  • Insulin resistance (IR) is increasingly linked to various cancers, but its role in melanoma is unclear.

Purpose of the Study:

  • To investigate the association between the triglyceride glucose (TyG) index, a marker of IR, and malignant melanoma incidence.
  • To evaluate the TyG index as a potential risk factor and diagnostic biomarker for melanoma.

Main Methods:

  • Retrospective analysis of 403 participants (272 melanoma, 131 nevi) from January 2019 to January 2024.
  • Collected data included demographics, BMI, fasting triglycerides, and fasting blood glucose.
  • Logistic regression and ROC curve analyses were used to assess the association between TyG index and melanoma risk.

Main Results:

  • Patients with malignant melanoma had significantly higher TyG index levels than the control group (P<0.001).
  • The TyG index was identified as an independent risk factor for melanoma incidence (OR, 6.33; P<0.001).
  • Melanoma incidence increased significantly across tertiles of the TyG index, with a clinically acceptable predictive cutoff identified.

Conclusions:

  • The triglyceride glucose (TyG) index is a significant risk factor for malignant melanoma incidence.
  • The TyG index shows potential as a valuable biomarker for melanoma diagnosis.
  • These findings may inform new melanoma treatment strategies and risk assessment protocols.